Viral Genetics Inc. Issues Company Update for First Half of 2010

SAN MARINO, Calif.--(BUSINESS WIRE)--New grants to its lead scientist have enabled biotech firm Viral Genetics, Inc., (Pink Sheets: VRAL), to accelerate the pace of its research, hire additional staff and move closer to its goal of bringing drug compounds to the marketplace. The company is testing drug therapies for autoimmune diseases, drug resistant cancers, strep, and staph, as well as investigating bio-fuels.

Back to news